Bio Green Med Solution receives Nasdaq notice over minimum bid price violation
BGMS•BGMS•BGMS•BGMS•Bio Green Med Solution received a Nasdaq deficiency notice after its shares traded below $1 for 30 consecutive business days. It has until April 27, 2027, to meet the minimum bid requirement or face a delisting notice.
Nasdaq notified Bio Green Med Solution on October 29, 2026, that it had violated the $1 minimum bid price requirement. The company has 180 days, through April 27, 2027, to achieve closing bids of at least $1 for 10 consecutive business days. The notice does not immediately affect its listing or trading, and its common stock continues to trade on Nasdaq under BGMS.
A proposed reverse stock split ranging from 1:4 to 1:16 requires shareholder approval and could help the company regain compliance. If it fails to do so within the allotted period, including any extensions, Nasdaq would issue a delisting notice, subject to appeal.
